5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Severe Acute Respiratory Syndrome Coronavirus 2 is the causative agent of Coronavirus Disease 2019 in humans. Among domestic animals, cats are more susceptible to SARS-CoV-2 than dogs. The detection of anti-SARS-CoV-2 antibodies in seemingly healthy cats and/or infected cats which are in close contact with infected humans has been described. The presence of animals that tested positive by serology or molecular techniques could represent a potential transmission pathway of SARS-CoV-2 that can spill over into urban wildlife. This study analyses the seroprevalence variation of SARS-CoV-2 in stray cats from different waves of outbreaks in a geographical area where previous seroepidemiological information of SARS-CoV-2 was available and investigate if SARS-CoV-2-seropositive cats were exposed to other co-infections causing an immunosuppressive status and/or a chronic disease that could lead to a SARS-CoV-2 susceptibility. For this purpose, a total of 254 stray cats from Zaragoza (Spain) were included. This analysis was carried out by the enzyme-linked immunosorbent assay using the receptor binding domain of Spike antigen and confirmed by serum virus neutralization assay. The presence of co-infections including Toxoplasma gondii, Leishmania infantum, Dirofilaria immitis, feline calicivirus, feline herpesvirus type 1, feline leukemia virus and feline immunodeficiency virus, was evaluated using different serological methods. A seropositivity of 1.57% was observed for SARS-CoV-2 including the presence of neutralizing antibodies in three cats. None of the seropositive to SARS-CoV-2 cats were positive to feline coronavirus, however, four SARS-CoV-2-seropositive cats were also seropositive to other pathogens such as L. infantum, D. immitis and FIV (n = 1), L. infantum and D. immitis (n = 1) and L. infantum alone (n = 1).Considering other pathogens, a seroprevalence of 16.54% was detected for L. infantum, 30.31% for D. immitis, 13.78%, for T. gondii, 83.86% for feline calicivirus, 42.52% for feline herpesvirus type 1, 3.15% for FeLV and 7.87% for FIV.

          Our findings suggest that the epidemiological role of stray cats in SARS-CoV-2 transmission is scarce, and there is no increase in seropositivity during the different waves of COVID-19 outbreaks in this group of animals. Further epidemiological surveillances are necessary to determine the risk that other animals might possess even though stray cats do not seem to play a role in transmission.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

          The ongoing pandemic spread of a novel human coronavirus, SARS-COV-2, associated with severe pneumonia disease (COVID-19), has resulted in the generation of tens of thousands of virus genome sequences. The rate of genome generation is unprecedented, yet there is currently no coherent nor accepted scheme for naming the expanding phylogenetic diversity of SARS-CoV-2. We present a rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread. Our system is made tractable by constraining the number and depth of hierarchical lineage labels and by flagging and de-labelling virus lineages that become unobserved and hence are likely inactive. By focusing on active virus lineages and those spreading to new locations this nomenclature will assist in tracking and understanding the patterns and determinants of the global spread of SARS-CoV-2.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

            Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the infectious disease COVID-19, which was first reported in Wuhan, China in December, 2019. Despite the tremendous efforts to control the disease, COVID-19 has now spread to over 100 countries and caused a global pandemic. SARS-CoV-2 is thought to have originated in bats; however, the intermediate animal sources of the virus are completely unknown. Here, we investigated the susceptibility of ferrets and animals in close contact with humans to SARS-CoV-2. We found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection. We found experimentally that cats are susceptible to airborne infection. Our study provides important insights into the animal models for SARS-CoV-2 and animal management for COVID-19 control.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

              A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies. We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein–specific, and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrated that most PCR-confirmed SARS-CoV-2–infected persons seroconverted by 2 weeks after disease onset. We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity. Overall, the validated assays described can be instrumental for detection of SARS-CoV-2–specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies.
                Bookmark

                Author and article information

                Contributors
                svs@unizar.es
                afmedica@unizar.es
                Journal
                Vet Res Commun
                Vet Res Commun
                Veterinary Research Communications
                Springer Netherlands (Dordrecht )
                0165-7380
                1573-7446
                14 October 2022
                : 1-15
                Affiliations
                [1 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Clinical Immunology Laboratory, Veterinary Faculty, , University of Zaragoza, ; 50013 Zaragoza, Spain
                [2 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Deparment of Animal Pathology, Veterinary Faculty, , University of Zaragoza, ; Zaragoza, Spain
                [3 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), ; Zaragoza, Spain
                [4 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Veterinary Teaching Hospital of the University of Zaragoza, ; Zaragoza, Spain
                [5 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Department of Animal Production and Sciences of the Food, Veterinary Faculty, , University of Zaragoza, ; Zaragoza, Spain
                [6 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, ; Edificio I+D, Campus Rio Ebro, Zaragoza, Spain
                [7 ]GRID grid.450869.6, ISNI 0000 0004 1762 9673, Aragon I+D Foundation (ARAID), ; Zaragoza, Spain
                [8 ]GRID grid.11205.37, ISNI 0000 0001 2152 8769, Laboratorio de Microscopías Avanzada (LMA), , University of Zaragoza, ; Edificio I+D, Campus Rio Ebro, Zaragoza, Spain
                [9 ]Copenhagen, Denmark
                [10 ]GRID grid.5254.6, ISNI 0000 0001 0674 042X, Department of Cellular and Molecular Medicine, School of Dentistry, , University of Copenhagen, ; Copenhagen, Denmark
                [11 ]GRID grid.488737.7, ISNI 0000000463436020, Aragon Health Research Institute (IIS Aragón), ; Zaragoza, Spain
                [12 ]GRID grid.413448.e, ISNI 0000 0000 9314 1427, CIBER de Enfermedades Infecciosas, , Instituto de Salud Carlos III, ; Madrid, Spain
                [13 ]GRID grid.412878.0, ISNI 0000 0004 1769 4352, Servicio de Análisis, Investigación, Gestión de Animales Silvestres (SAIGAS), Facultad de Veterinaria, , Universidad Cardenal Herrera-CEU, ; Valencia, Spain
                Article
                10016
                10.1007/s11259-022-10016-7
                9560875
                36229725
                738055ff-4610-4542-b5ae-b87579bcc0bd
                © The Author(s), under exclusive licence to Springer Nature B.V. 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 18 April 2022
                : 6 October 2022
                Categories
                Research

                Veterinary medicine
                covid-19, stray cats,elisa,sars-cov-2,serology,vnt
                Veterinary medicine
                covid-19, stray cats, elisa, sars-cov-2, serology, vnt

                Comments

                Comment on this article